LDOS vs ZVRA · P/E 16, rev $8.96B vs P/E 6.3, rev $75.9M
Leidos Holdings Inc (LDOS) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported LDOS revenue for 2026-07-03 was $8.96B. Net income was $682.0M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
LDOS currently screens at market cap $20.04B and trailing P/E 15.7. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the LDOS and ZVRA stock pages for the full models.
Not investment advice.